Titan Medical (TSX:TMD;OTC:TITFX) announced today that it received two U.S. patents for its robotic surgical systems.
Toronto-based Titan Medical’s two latest patents bring its global intellectual property portfolio to 58 issued patents and 84 patent applications, according to a news release. Additionally, the company has received notices of allowance in 17 other patent applications and anticipates issuance in the coming months.
U.S. Patent No. 10,772,703, titled “Methods and apparatuses for positioning a camera of a surgical robotic system to capture images inside a body cavity of a patient during a medical procedure,” is directed at the autonomous positioning of a camera in response to the location of a surgical instrument.
The second patent, No. 10,758,311, titled “Hand controller apparatus for gesture control and shared input control in a robotic surgery system,” is for a novel robotic hand controller for controlling one or more robotic functions, including a camera.
Titan believes the new patents cover various aspects of robotic surgery instrumentation, autonomous error correction, imaging sensors, visual illumination, graphical user interfaces and sterile barriers.
“I commend Jasminder Brar, our [VP] of legal, IP and strategic initiatives, for his leadership and foresight in formulating an intellectual property strategy that continues to create significant value for Titan’s stakeholders,” Titan president & CEO David McNally said in the release. “As evidenced by our recent strategic announcements, intellectual property is fundamental to Titan’s success, providing a foundation to product commercialization, mitigating against certain risks, protecting the company’s innovations and facilitating value creation.
“While we are always excited to obtain new patents and allowances, the issuance of these recent patents is especially exciting as they relate to human-machine interaction, an area where we have paid special attention in advancing the ergonomic friendliness of medical robotics based on feedback from surgeons.”
